Yesterday The New York Times featured a front-page story suggesting that the approach the government cancer research funding, particularly at the national Institutes of Health (NIH) scientists -pushes to "play it safe" and steer clear of bold ideas. The article, by Gina Kolata, addressed the scientific points have complained for years, and has generated a storm of comments mostly positive on Times website. More than 0 people have weighed in so far, many of them frustrated researchers, grant their authors, and others inside and outside the field of cancer.
A number of scientists, both those comments and those mentioned in the original article, said it was not always bad. They attribute some caution to years of tight budgets under the Bush administration. Several speakers defended the current system, especially at a time of difficult funding: "There is a limited amount of money VERY limited," wrote Rosa Ohio, who said she has reviewed grants. NIH for the last 8 years. "We can not finance all the wild ideas without any proof of the basic feasibility."
But from the sound of it, there is a desire among some at least, to the wildest studies over those tamed in the hope that they will actually make a difference.
0 Komentar